Christopher Langmead

Christopher Langmead

Company: Amgen

Job title: Director, Digital Biologics Discovery


Panel Discussion: Using Deep & Machine Learning Methods to Develop & Optimize Therapeutic Anti-bodies 9:30 am

Revealing the pillars for ML-based optimization of therapeutic antibodies Outlining recent progress in the application of ML methods for antibody optimization Comparing organizational strategies for developing optimal therapeutic antibodiesRead more

day: Day Two

Addressing the Design & Engineering of Multi-specific, Multifunctional Antibodies to Advance the Constructs in-Vivo and into the Clinic 4:30 pm

Discussing advances in the development of multifunctional antibodies with favourable stability, specificity, and pharmacokinetic properties Exploring Emerging computational methods for enhancing the next generation of multi-specific antibodies Leveraging current know-how by translating learnings from IgG1 design to multispecificsRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.